Boston University
Differential analysis of clinical and molecular markers from type 2 diabetes mellitus human vascular endothelial cells
Abstract
dc:description.abstractEndothelial dysfunction is a key contributor to cardiovascular disease in type 2 diabetes mellitus (T2DM) and is closely linked to impaired insulin signaling and reduced nitric oxide (NO) bioavailability. Insulin normally promotes endothelial NO production through activation of the PI3K/AKT pathway and subsequent phosphorylation of endothelial nitric oxide synthase (eNOS) at serine 1177. In T2DM, this pathway may be disrupted, contributing to vascular dysfunction. Objective The objective of this study was to evaluate differences in insulin-stimulated eNOS activation in endothelial cells from individuals with T2DM compared to non-diabetic controls, and to assess the relationship between endothelial signaling and cardiometabolic characteristics. Methods Endothelial cells were collected from non-diabetic control participants (n=16) and individuals with T2DM (n=23). Cells were stimulated ex vivo with insulin, and phosphorylation of eNOS at serine 1177 (p-eNOS) was quantified using mean fluorescence intensity (MFI). Relative changes in p-eNOS following insulin stimulation were calculated as fold change and percent change from baseline. Clinical characteristics, including anthropometric measures, glycemic indices, and lipid profiles, were obtained from fasting blood samples and standardized clinical assessments. Statistical comparisons between groups were performed using two-sided t-tests and chi-square analyses, with p<0.05 considered statistically significant. Results Participants with T2DM exhibited significantly higher body mass index, fasting glucose, HbA1c, fasting insulin, and triglyceride levels, along with lower HDL cholesterol, compared to controls. Insulin stimulation increased p-eNOS MFI in control participants but resulted in a decreased response in T2DM participants. The ratio of insulin-stimulated to baseline p-eNOS was significantly higher in controls compared to T2DM (1.38±0.41 vs 0.85±0.13, p<0.00001). Similarly, percent change in p-eNOS was positive in controls (+38.0±40.7%) and negative in T2DM participants (−15.2±13.3%, p<0.00001). Conclusions Endothelial cells from individuals with T2DM demonstrate impaired insulin-stimulated eNOS activation, consistent with endothelial insulin resistance. The observed reduction and reversal of p-eNOS response to insulin highlight a key defect in nitric oxide signaling that may contribute to vascular dysfunction and increased cardiovascular risk in T2DM. These findings underscore the importance of targeting endothelial signaling pathways in the management of diabetes-related vascular disease.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ezenekwe, Chiazom
- Advisors dc:contributor.advisor
-
- Gerstenfeld, Louis
- Hamburg, Naomi
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53518